SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I - Tender offer statement by Issuer:
SEC Accession No. 0001493152-19-013149
Filing Date
2019-08-20
Accepted
2019-08-20 17:01:47
Documents
5

Document Format Files

Seq Description Document Type Size
1 formscto-i.htm SC TO-I 137830
2 exa1a.htm EX-99 424548
3 exa1a_001.jpg GRAPHIC 2716
4 exa1b.htm EX-99 197738
5 exa1b_001.jpg GRAPHIC 2716
  Complete submission text file 0001493152-19-013149.txt   770015
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filed by) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Subject) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I | Act: 34 | File No.: 005-36676 | Film No.: 191040404
SIC: 2834 Pharmaceutical Preparations